OT Staff Reports


Prevent Blindness: July is Dry Eye Awareness Month

The organization hopes to increase awareness and education of a condition that affects vision, mental health.

Efficacy of Notal Vision OCT device demonstrated by a series of scientific and clinical work

Investigators show the effectiveness of Home-OCT based remote monitoring model.

Oculis announces first patient enrolled in Phase 3 OPTIMIZE trial

OCS-01 is being reviewed for the treatment of inflammation and pain after cataract surgery, with the potential to become the first once-daily, topical and preservative-free corticosteroid for treating inflammation and pain following ocular surgery.

RegeneRx licensee to expand Phase 3 clinical trial program with RGN-259

June 24, 2022

RegeneRx Biopharmaceuticals Inc. said its U.S. joint venture partner and licensee, HLB Therapeutics, will expand its ophthalmic clinical development program with RGN-259 in two indications, neurotrophic keratopathy and dry eye disease.